Skip to search.
 TSX Down 0.04% TSX Ventures Up 0.83%

Biogen Idec Inc. (BIIB)

-NasdaqGS
409.59 Down 0.51(0.12%) Feb 27, 4:00PM EST
|After Hours : 409.59 0.00 (0.00%) Feb 27, 5:03PM EST
Add to Portfolio
Prev Close:410.10
Open:410.23
Bid:406.10 x 100
Ask:N/A
1y Target Est:419.83
Beta:0.56
Earnings Date:Apr 21 - Apr 27 (Est.)
Day's Range:405.80 - 411.31
52wk Range:272.02 - 412.02
Volume:1,371,021
Avg Vol (3m):1,800,020
Market Cap:96.10B
P/E (ttm):33.11
EPS (ttm):12.37
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BIIBDown 0.12%96.10B
PFEDown 0.78%216.24B

Key Statistics

Forward P/E (1 yr):20.57
P/S (ttm):9.92
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :16.96
Quarterly EPS Est (Mar-15) :3.91
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurological, autoimmune, and hematologic disorders in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback